Our client 2EyesVision raises €2 M to drive its global expansion

We echo the news shared by Carlos Dorronsoro Díaz, the company’s CEO, because we feel part of the leap 2EyesVision is making.

Context

On 30 April 2025, our client 2EyesVision — a pioneer in ophthalmology technology — announced the opening of a €2 million funding round. The round already has €950 k committed by Bullnet Capital and Innvierte‑CDTI and is reinforced with a €300 k ENISA Crecimiento loan. The goal: to accelerate time‑to‑market, strengthen sales and marketing, and consolidate the technological development that underpins its new recurring‑revenue model.

Source: Europapress

Why is this a key piece of news for the health‑tech sector?

• Market in full swing. Demand for solutions that improve patient experience and optimise clinical decision‑making is growing at double digits.
• Investor traction validated. The continued backing of deep‑tech funds such as Bullnet Capital and public bodies like CDTI sends a clear signal to the market.
• International roadmap. The capital raised accelerates the global rollout of the SimVis Gekko2 visual simulator, its latest‑generation device, and paves the way to break‑even in less than three years.

Our role in 2EyesVision’s success

For a cutting‑edge medical device to become a scalable business, hardware alone is not enough: it needs a robust, secure digital platform that is ready to grow. That’s where we come in:

Comprehensive clinic control: Web dashboard that enables the management of clinics, devices, suppliers and other entities involved in the ecosystem.

Lens and SimVis management: System that allows lenses to be configured and synchronised with each SimVis in real time.

Clinical records & reporting: Usage history, encrypted patient data and PDF report generation with detailed evaluations.

Mobility for medical teams: iOS app that connects via Bluetooth® with SimVis to configure lens simulations, record results and securely upload data to the cloud.

We wish the very best for this funding round and the new stage of the project, while we continue developing an ever more complete and robust system for 2EyesVision.